Merocarb

Meropenem, the active ingredient in Merocarb, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, hospital‑acquired pneumonia, complicated urinary tract infections, septicemia, and skin and soft‑tissue infections in hospitalized and critically ill patients.

GNH USA supplies Merocarb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality assurance and regulatory compliance across all markets, and supports antimicrobial stewardship programs.

Merocarb (meropenem) is a broad‑spectrum carbapenem antibiotic used to treat serious bacterial infections.

- Complicated intra‑abdominal infections: effective bacterial eradication in patients with intra‑abdominal sepsis. - Hospital‑acquired pneumonia: rapid clearance of pathogenic organisms in ventilated patients. - Complicated urinary tract infections: resolves infection when other agents fail. - Septicemia: provides bactericidal activity in bloodstream infections. - Skin and soft‑tissue infections: treats deep tissue infections caused by resistant Gram‑negative bacteria.

Adverse reactions may occur with any antimicrobial therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be self‑limited or indicate colitis. - Rash: localized skin erythema. - Injection site reactions: pain, erythema, or swelling at the infusion site.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: risk increases with high doses or renal impairment. - Clostridioides difficile‑associated diarrhea: may lead to colitis. - Renal toxicity: elevated creatinine or reduced urine output.

Use meropenem with caution in specific clinical situations. - Renal function: assess and adjust dose in patients with impaired kidney function. - Hypersensitivity: avoid in individuals with known carbapenem or β‑lactam allergy. - Seizure risk: monitor patients with central nervous system disorders or receiving high doses. - Pregnancy: prescribe only when the potential benefit justifies the potential risk to the fetus. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines; monitoring is advised.

Major Interactions (Avoid): - Valproic acid: meropenem reduces serum valproate levels, risking seizure breakthrough. - Probenecid: may increase meropenem plasma concentrations, enhancing toxicity. - Concurrent nephrotoxic agents (e.g., aminoglycosides): heightened risk of renal injury.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance of meropenem. - NSAIDs: combined use can impair kidney function. - Warfarin: monitor INR as meropenem may alter anticoagulant effect.